Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) announced that it has established collaborations with several tuberculosis (TB) medical care facilities to initiate the data collection and screening of active respiratory challenged patients.
The company said the potential for a non-invasive, non-sputum-based and point-of-care mobile app holds significant promise for efficiently triaging and aiding health care professionals to make an informed decision on respiratory issues in developed and underdeveloped parts of the world.
“This data collection effort will allow us to match medical histories, patient vitals, acoustic cough samples and other salient data points from active TB patients, which will eventually help us create one of the most valuable databases in the world for respiratory illness research,” Therma Bright CEO Rob Fia said in a statement.
“This effort offers a route to help expedite the deployment of a new innovative App to screen and monitor TB and other respiratory illnesses, which ultimately will save communities time, money and lives,” he added.
Therma Bright noted that its licensed Digital Cough Technology (DCT), from AI4LYF, offers a tremendous opportunity for Therma Bright and developing communities to lead the way, bringing AI-driven, real-life validated digital collection, screening and user-friendly technology to the global marketplace.
The company added that it has embarked on a digital collection effort with its licensing partner, AI4LYF, with the goal of securing cough data via its innovative AI-driven DCT App.
The data collected will be in partnership with several hospitals across Pakistan, a nation where TB has reached a concerning public health threat, Therma Bright said.
As well, Therma Bright stated that the company and AI4LYF are currently working with these TB medical care facilities to begin the digital data collection from their most active patients.
Therma Bright is a developer and partner in a range of leading-edge, proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with quality, innovative solutions that address some of today's most important medical and healthcare challenges.
Contact Sean at sean@proactiveinvestors.com